ChiCTR2600127072 版本V1.0 版本创建时间2026/06/24 10:48:50 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600127072 

最近更新日期:

Date of Last Refreshed on:

2026-06-24 10:48:41 

注册时间:

Date of Registration:

2026-06-24 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

2015年-2025年中国商洛市手足口病病原学监测及时空分析

Public title:

Scientific title Pathogen surveillance and spatiotemporal analysis of HFMD in Shangluo City, China, 2015-2025

注册题目简写:

商洛市手足口病发病情况时空分布回顾调查

English Acronym:

Public title A retrospective spatiotemporal survey of HFMD in Shangluo City, China

研究课题的正式科学名称:

2015年-2025年中国商洛市手足口病病原学监测及时空分析

Scientific title:

Scientific title Pathogen surveillance and spatiotemporal analysis of HFMD in Shangluo City, China, 2015-2025

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

齐延亮 

研究负责人:

齐延亮 

Applicant:

Yanliang Qi 

Study leader:

Yanliang Qi 

申请注册联系人电话:

Applicant telephone:

+86 18729893085

研究负责人电话:

Study leader's
telephone:

+86 914 2395157

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

heroqyl@163.com

研究负责人电子邮件:

Study leader's E-mail:

382696822@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

陕西省商洛市商州区通信路信息巷西段检验科,726000

研究负责人通讯地址:

通信路信息巷

Applicant address:

Xinxi Lane, Tongxin Road, Shangzhou District, Shangluo City, Shaanxi, China, 726000

Study leader's address:

Information Lane, Communication Road, Shangzhou District, Shangluo City, Shaanxi Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

商洛市疾病预防控制中心

Applicant's institution:

Shangluo Center for Disease Control and Prevention

研究负责人所在单位:

商洛市疾病预防控制中心

Affiliation of the Leader:

Shangluo City Center For Disease Control And Prevention

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

[2026]伦审第(002)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

商洛市疾病预防控制中心伦理委员会

Name of the ethic committee:

Research Ethics Committee of Shangluo City Center for Disease Control and Prevention

伦理委员会批准日期:

Date of approved by ethic committee:

2026-06-19 00:00:00

伦理委员会联系人:

张佩

Contact Name of the ethic committee:

Pei Zhang

伦理委员会联系地址:

通信路信息巷

Contact Address of the ethic committee:

Information Lane, Communication Road, Shangzhou District, Shangluo City, Shaanxi Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 914 2338840

伦理委员会联系人邮箱:

Contact email of the ethic committee:

573057217@qq.com

研究实施负责(组长)单位:

商洛市疾病预防控制中心

Primary sponsor:

Shangluo City Center For Disease Control And Prevention

研究实施负责(组长)单位地址:

通信路信息巷

Primary sponsor's address:

Information Lane, Communication Road, Shangzhou District, Shangluo City, Shaanxi Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

陕西

市(区县):

Country:

China

Province:

Shaanxi

City:

单位(医院):

商洛市疾病预防控制中心

具体地址:

通信路信息巷

Institution
hospital:

Shangluo City Center For Disease Control And Prevention

Address:

Information Lane, Communication Road, Shangzhou District, Shangluo City, Shaanxi Province

经费或物资来源:

自选课题(自筹)

Source(s) of funding:

Self-funded

研究疾病:

手足口病  

Target disease:

Hand, foot and mouth disease

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

横断面 

Study design:

Cross-sectional 

研究目的:

描述2015-2025年商洛市手足口病病原学谱构成、时空分布特征及发病趋势,识别高发区域和高发人群,为当地手足口病精准防控提供科学依据。  

Objectives of Study:

To describe the pathogen spectrum, spatiotemporal distribution characteristics, and incidence trends of hand, foot and mouth disease in Shangluo City from 2015 to 2025, and to identify high-risk areas and populations, so as to provide scientific evidence for local prevention and control strategies.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.2015年1月1日至2025年12月31日期间,商洛市各级医疗机构报告的手足口病临床诊断或实验室确诊病例; 2.病例信息完整(含发病日期、年龄、性别、现住址); 3.实验室确诊病例需有病原学检测结果;

Inclusion criteria

1.Clinically diagnosed or laboratory-confirmed HFMD cases reported by medical institutions in Shangluo City between January 1, 2015 and December 31, 2025;
2.Cases with complete information (onset date, age, sex, address);
3.Laboratory-confirmed cases with pathogen testing results.

排除标准:

1.重复报告病例;
2.发病日期、年龄、现住址等关键信息缺失的病例;
3.临床诊断病例中病原型别不明者(若仅分析实验室确诊病例);

Exclusion criteria:

1.Duplicate reported cases;
2.Cases with missing key information (onset date, age, address);
3.Clinically diagnosed cases without pathogen typing (if only analyzing laboratory-confirmed cases).

研究实施时间:

Study execute time:

From 2026-06-19 00:00:00 To 2026-07-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-06-24 00:00:00 To 2026-07-24 00:00:00

干预措施:

Interventions:

组别:

观察组

样本量:

15000

Group:

Observation group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

陕西 

市(区县):

 

Country:

China

Province:

Shaanxi

City:

单位(医院):

商洛市疾病预防控制中心 

单位级别:

无 N/A 

Institution
hospital:

Shangluo City Center For Disease Control And Prevention

Level of the institution:

N/A

测量指标:

Outcomes:

指标中文名:

手足口病发病率、

指标类型:

主要指标

Outcome:

Incidence rate of HFMD

Type:

Primary indicator

测量时间点:

不适用(回顾性分析)

测量方法:

病原学检测(实时荧光定量PCR)

Measure time point of outcome:

Not applicable (retrospective)

Measure method:

Real-time fluorescence quantitative PCR

指标中文名:

病原体检出率

指标类型:

主要指标

Outcome:

Pathogen detection rate

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

NA

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

论文发表后,数据将以匿名化形式存储于Figshare或Zenodo等开放数据平台,并提供DOI链接。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

The way of sharing IPD De-identified data will be deposited in a public repository (e.g., Figshare or Zenodo) upon publication, with a DOI link provided.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据来源于商洛市疾控中心2015-2025年手足口病监测数据库及中国疾病预防控制信息系统。由2名研究人员独立进行数据提取和核对,采用Excel建立原始数据库,双人双录入并交叉比对。分析前进行数据清洗,处理缺失值和异常值。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data collection and Management Data were extracted from the HFMD surveillance database of Shangluo CDC (2015-2025) and the China CDC Information System. Two researchers independently extracted and verified the data. An Excel database was established with double-entry and cross-checking. Data cleaning was performed prior to analysis.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2026-06-24 10:48:41